Human cytomegalovirus: Latency and reactivation in the myeloid lineage
- PMID: 18164651
- DOI: 10.1016/j.jcv.2007.11.014
Human cytomegalovirus: Latency and reactivation in the myeloid lineage
Abstract
Human cytomegalovirus (HCMV) persists as a sub-clinical, lifelong infection in the human host which is maintained at least in part by its carriage in the absence of detectable infectious virus: a hallmark of latent infection. In contrast, reactivation from latency in immuno-compromised individuals can result in serious disease. Understanding virus latency and reactivation, therefore, is essential for a full understanding of the biology and pathogenesis of this persistent human herpesvirus. However, the precise cellular sites in which HCMV is carried and the mechanisms regulating its latency and reactivation, during natural infection, remain poorly understood. Recent work, however, has led to a consensus opinion that cells of the myeloid lineage are one site of carriage of HCMV in vivo and that in myeloid dendritic cell (DC) progenitors the viral genome is carried latently in the absence of virus lytic gene expression. In contrast, differentiation of these cells to a mature DC phenotype is linked with reactivation of infectious virus resulting from differentiation-dependent chromatin remodelling of the viral major immediate-early promoter. Thus there is a crucial link between the differentiation of myeloid cells and transcriptional reactivation of latent virus which is likely to play a key role in viral pathogenesis.
Similar articles
-
Latency and reactivation of human cytomegalovirus.J Gen Virol. 2006 Jul;87(Pt 7):1763-1779. doi: 10.1099/vir.0.81891-0. J Gen Virol. 2006. PMID: 16760381 Review.
-
Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers.Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4140-5. doi: 10.1073/pnas.0408994102. Epub 2005 Feb 28. Proc Natl Acad Sci U S A. 2005. PMID: 15738399 Free PMC article.
-
Inhibition of inflammatory interleukin-6 activity via extracellular signal-regulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells.J Virol. 2011 Dec;85(23):12750-8. doi: 10.1128/JVI.05878-11. Epub 2011 Sep 21. J Virol. 2011. PMID: 21937636 Free PMC article.
-
Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.J Virol. 2014 Aug;88(16):9391-405. doi: 10.1128/JVI.00934-14. Epub 2014 Jun 11. J Virol. 2014. PMID: 24920803 Free PMC article.
-
Aspects of human cytomegalovirus latency and reactivation.Curr Top Microbiol Immunol. 2008;325:297-313. doi: 10.1007/978-3-540-77349-8_17. Curr Top Microbiol Immunol. 2008. PMID: 18637513 Review.
Cited by
-
The Immune Modulatory Role of TIF1 Proteins.Adv Exp Med Biol. 2024;1466:89-99. doi: 10.1007/978-981-97-7288-9_6. Adv Exp Med Biol. 2024. PMID: 39546137 Review.
-
HCMV strain- and cell type-specific alterations in membrane contact sites point to the convergent regulation of organelle remodeling.J Virol. 2024 Nov 19;98(11):e0109924. doi: 10.1128/jvi.01099-24. Epub 2024 Oct 31. J Virol. 2024. PMID: 39480111
-
Virus-Specific Nanobody-Chimeras Degrade the Human Cytomegalovirus US28 Protein in CD34+ Cells.Pathogens. 2024 Sep 24;13(10):821. doi: 10.3390/pathogens13100821. Pathogens. 2024. PMID: 39452693 Free PMC article.
-
Retinal detachment and mortality in patients with cytomegalovirus retinitis: A multicenter study in taiwan.Graefes Arch Clin Exp Ophthalmol. 2024 Oct 18. doi: 10.1007/s00417-024-06651-2. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 39422751
-
An epigenetic human cytomegalovirus infection score predicts viremia risk in seropositive lung transplant recipients.Epigenetics. 2024 Dec;19(1):2408843. doi: 10.1080/15592294.2024.2408843. Epub 2024 Oct 3. Epigenetics. 2024. PMID: 39360678 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources